<DOC>
	<DOCNO>NCT01923714</DOCNO>
	<brief_summary>This study aim validate real-life clinical practice use self-reported Glaucoma Symptom Scale ( GSS ) questionnaire , impact switch preservative-free dorzolamide/timolol fix combination ( DTFC ) patient use preserved topical therapy glaucoma .</brief_summary>
	<brief_title>Impact Tolerability Switch Dorzolamide/Timolol Preservative-free Fixed Combination Ocular Surface Symptoms</brief_title>
	<detailed_description>The study 8-week multi-center , prospective , observational non-interventional , open-label study aim assess change visual-related quality life glaucoma patient switch therapy preservative-free DTFC . As non-interventional study , decision switch discretion physician . Patients scheduled switch therapy preservative free DTFC ask fill 10 item , linkert-type GSS questionnaire baseline , week 4 week 8 therapy switch . The study data collect baseline 2 follow-up visit occur 4 week +/- 1 week 8 week +/- 1 week . If visit schedule , patient ask send complete document physician .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<criteria>Adults patient age 18 year old inclusion visit Diagnosed OAG one eye Who use previous preserve eye drop treatment least 4 week one eye eye Experiencing preestablished ocular surface disease symptom , define 2007 report International Dry Eye Workshop Being schedule ophthalmologist switch preservativefree DTFC eye drop ( monotherapy replacement one preserve product combine therapy ) inclusion visit due tolerability issue Accepting participate study provide write informed consent Patients filter ocular surgery within 6 month precede inclusion visit Who already treat preservativefree DTFC Whose visual acuity importantly impair severe ocular disease OAG , assess physician Currently involve clinical trial study cohort pharmacoepidemiology study interventional study With serious mental physical disability could interfere patientreported assessment Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Glaucoma</keyword>
</DOC>